Diplomat to Release 2018 Financial Results, 2019 Guidance Feb. 25

01/28/2019
The nation's largest independent provider of specialty pharmacy and infusion services will discuss Q4 and year-end 2018 results -- plus guidance for 2019 -- in a conference call Feb. 25.

FLINT, Mich., Jan. 28, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will report its fourth-quarter and year-end 2018 financial results — and provide 2019 guidance — after market close Monday, Feb. 25. A conference call and live webcast will follow at 5 p.m. ET.

Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.)

Shareholders and other interested parties can listen to the conference call live by dialing 833.286.5805 (647.689.4450 for international callers). Participation code 2672528 will start working about 15 minutes before the call. A live webcast will be available on the investor relations section of Diplomat's website at ir.diplomat.is. An audio recording and related materials will be available online for approximately 90 days.

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.

CONTACT:

Terri Anne Powers, Vice President of Investor Relations
312.889.5244 | tpowers@diplomat.is

Elizabeth Carr, Corporate Communications Manager
810.768.9871 | press@diplomat.is

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-to-release-2018-financial-results-2019-guidance-feb-25-300784974.html

SOURCE Diplomat Pharmacy, Inc.

NYSE: DPLO

-0.10 -1.81% $ 5.41 Volume: 27,144 Common Stock | 20 minute delay April 25, 2019

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now